PT
Pelthos Therapeutics Inc.
SEC filingPharmaceuticals · Durham, NC
Amount raised$18Msold at filing
Total offering$18M
Investors in the raise8count reported to the SEC
FiledNov 19, 2025first sale Nov 6, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Matthew PaulsDirector
Peter GreenleafDirector
Richard BaxterDirector
Richard MalamutDirector
Todd DavisDirector
Francis Knuettel IIExecutive Officer
Sai RangaraoExecutive Officer
Scott PleshaExecutive Officer, Director
Ezra FriedbergDirector
Executive officers, directors and promoters as listed on the Form D.